Chemically modified dextrans modulate expression of collagen phenotype by cultured smooth muscle cells in relation to the degree of carboxymethyl, benzylamide, and sulfation substitutions

Journal of Biomedical Materials Research

Volumn 42, Issue 2, 1998, Pages 286-294

  Mestries, Patricia ^a   Borchiellini, Carole ^a   Barbaud, Christel ^a   Duchesnay, Arlette ^a   Escartin, Quentin ^a   Barritault, Denis ^a   Caruelle, Jean Pierre ^a   Kern, Patrick ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Antifibrosis; Atheroscterosis; Collagen; RGTA heparin like

Indexed keywords

AGENTS; ANIMAL CELL CULTURE; BIOSYNTHESIS; CHEMICAL MODIFICATION; COLLAGEN; MUSCLE; POLYSACCHARIDES; RNA;

BIOACTIVITY; DEXTRANS; REGENERATING AGENTS; SULFATION;

BIOMATERIALS;

BENZYL DERIVATIVE; CARBOXYMETHYLDEXTRAN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DEXTRAN DERIVATIVE; HEPARIN; MESSENGER RNA; POLYSACCHARIDE; SULFATE;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FIBROSIS; NONHUMAN; SMOOTH MUSCLE FIBER; SULFATION; SWINE;

ANIMALS; ANIMALS, NEWBORN; AORTA; BIOCOMPATIBLE MATERIALS; CELL DIVISION; CELLS, CULTURED; COLLAGEN; DEXTRANS; MUSCLE, SMOOTH, VASCULAR; SWINE;

EID: 0032210764     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(199811)42:2<286::AID-JBM14>3.0.CO;2-H     Document Type: Article

References (35)

1. R. Ross, "The pathogenesis of atherosclerosis: A perspective for the 1990s," Nature, 362, 801-809 (1993).
2. H. C. Stary, A. B. Chandler, R. E. Dinsmore, V. Fuster, S. Glagov, W. Insull, Jr., M. E. Resenfeld, C. J. Schwartz, W. D. Wagner, and R. W. Wissler, "A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis," Circulation, 92, 1355-1374 (1995).
3. G. R. Campbell and J. H. Campbell, "Phenotypic modulation of smooth muscle cells in primary culture," in Vascular Smooth Muscle Cells in Primary Culture, J. H. Campbell and G. R. Campbell (eds.), CRC Press, Inc., Boca Raton, Florida, 1987, pp. 39-55.
4. A. K. Ang, G. Tachas, J. H. Campbell, J. F. Bateman, and G. R. Campbell, "Collagen synthesis by rabbit cultured smooth muscle cells. Alteration with phenotype," Biochem. J., 265, 461-469 (1990).
5. A. K. Majors and L. A. Erhart, "Cell density and proliferation modulate collagen synthesis and procollagen mRNA levels in arterial smooth muscle cells," Exp. Cell Res., 200, 168-174 (1992).
6. M. Yamamoto, K. Yamamoto, and T. Noumura, "Type I collagen promotes modulation of cultured rabbit smooth muscle cells from contractile to synthetic phenotype," Exp. Cell Res., 204, 121-129 (1993).
7. J. R. Guyton, R. D. Rosenberg, A. W. Clowes, and M. J. Karnovsky, "Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and non-anticoagulant heparin," Circ. Res., 46, 625-634 (1980).
8. C. F. Reilly, M. S. Kindy, K. E. Brown, R. D. Rosenberg, and G. E. Sonenshein, "Heparin prevents vascular smooth muscle cells progression through the G1 phase of the cell cycle," J. Biol. Chem., 264, 6990-6995 (1989).
9. A. Schmidt, K. Yoshida, and E. Buddecke, "The antiproliferative activity of arterial heparan sulfate resides in domains enriched with 2-O-sulfated uronic acid residues," J. Biol. Chem., 267, 19242-19247 (1992).
10. r 60,000 collagen," J. Cell Biol., 100, 613-619 (1985).
11. A. D. Snow, R. P. Bolender, T. N. Wight, and A. W. Clowes, "Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells," Am. J. Pathol., 137, 313-330 (1990).
12. C. Asselot-Chapel, P. Kern, and J. Labat-Robert, "Biosynthesis of interstitial collagens and fibronectin by porcine aortic smooth muscle cells. Modulation by low molecular weight heparin fragments," Biochim. Biophys. Acta, 993, 240-244 (1989).
13. C. Asselot-Chapel, L. Combacou, J. Labat-Robert, and P. Kern, "Expression of fibronectin and interstitial collagen genes in smooth muscle cells: Modulation by low molecular weight heparin fragments and serum," Biochem. Pharmacol., 49, 653-659 (1995).
14. M. Tardieu, C. Gamby, T. Avramoglou, J. Jozefonvicz, and D. Barritault, "Derivatized dextrans mimic heparin as stabilizers, potentiators and protectors of acid and basic FGF," J. Cell. Physiol., 150, 194-203 (1992).
15. Y. Benazzoug, D. Logeart, J. Labat-Robert, L. Robert, J. Jozefonvicz, and P. Kern, "Derivatized dextrans modulate collagen synthesis in aortic smooth muscle cells," Biochem. Pharmacol., 49, 847-853 (1995).
16. D. Logeart, D. Letourneur, J. Jozefonvicz, and P. Kern, "Collagen synthesis by vascular smooth muscle cells in the presence of antiproliferative polysaccharides," J. Biomed. Mater. Res., 30, 501-508 (1996).
17. A. Aamiri, G. S. Butler-Browne, I. Martelly, D. Barritault, and J. Gautron, "Influence of a dextran derivative on myosin heavy chain expression during rat skeletal muscle regeneration," Neurosci. Lett., 201, 243-246 (1995).
18. J. Gautron, C. Kedzia, I. Husmann, and D. Barritault, "Injection of heparan sulfate-like substance in a crushed muscle accelerates its regeneration," CR Acad. Sci. Paris., 318, 671-676 (1995).
19. T. C. Wright, J. J. Castellot, M. Petitou, J. C. Lormeau, C. Choay, and M. J. Karnovsky, "Structural determinants of heparin's growth inhibitory activity: Interdependency of oligosaccharide size and charge," J. Biol. Chem., 264, 1534-1542 (1989).
20. M. Mauzac and J. Jozefonvicz, "Anticoagulant activity of dextran derivatives. I. Synthesis and characterization," Biomaterials, 5, 301-304 (1984).
21. F. Chaubet, J. Champion, O. Maiga, S. Mauray, and J. Jozefonvicz, "Synthesis and structure-anticoagulant property relationships of functionalized dextrans," Carbohydrate Polym., 28, 145-152 (1995).
22. M. Wiestner, H. Rohde, O. Helle, R. Timpl, and P. K. Muller, "Low rate of procollagen conversion in dermatosparatic sheep fibroblasts is paralleled by increased synthesis of type I and type III collagen," EMBO J., 1, 513-516 (1982).
23. P. Chromczynski and N. Sacchi, "Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction," Anal. Biochem., 162, 156-159 (1987).
24. M. L. Chu, J. C. Myers, M. J. Bernard, S. F. Ding, and F. Ramirez, "Cloning and characterization of five overlapping cDNAs specific for the human pro-alpha 1(I) collagen," Nucl. Acids Res., 10, 5925-5934 (1982).
25. M. Sandberg and E. Vuorio, "Localization of types I, II, III collagen mRNAs in developing human skeletal tissues by in situ hybridation," J. Cell Biol., 104, 1077-1084 (1987).
26. D. Weil, M. J. Bernard, S. Gargano, and F. Ramirez, "The pro-alpha 2(V) collagen gene is evolutionarily related to the major fibrillar-forming collagen," Nucl. Acids Res., 15, 181-198 (1987).
27. P. Fort, L. Marty, M. Piechaczyk, S. Sabrouty, C. Dani, P. Jeanteur, and J. M. Blanchard, "Various adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-deshydrogenase multigenic family," Nucl. Acids Res., 13, 1431-1442 (1985).
28. A. Yayon, M. Klagsbrun, J. D. Esko, P. Leder, and D. M. Ornitz, "Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor," Cell 64, 841-848 (1991).
29. V. A. Ferrao and R. M. Mason, "The effect of heparin on cell proliferation and type-I collagen synthesis by adult human dermal fibroblasts," Biochim. Biophys. Acta, 1180, 225-230 (1993).
30. A. Meddahi, J. Benoit, N. Ayoub, A. Sezeur, and D. Barritault, "Heparin-like polymers derived from dextran-enhanced colonic anastomosis resistance to leakage," J. Biomed. Mater. Res., 31, 293-297 (1996).
31. A. Majors and L. A. Ehrhart, "Basic fibroblast growth factor in the extracellular matrix suppresses collagen synthesis and type III procollagen mRNA levels in arterial smooth muscle cell culture," Arterioscler. Thromb. 13, 680-686 (1993).
32. R. Lawrence, D. Hartmann, and G. E. Sonenshein, "Transforming growth factor β1 stimulates type V collagen expression in bovine vascular smooth muscle cells," J. Biol. Chem., 269, 9603-9609 (1994).
33. J. F. Bateman and S. B. Golub, "Assessment of procollagen processing defects by fibroblasts cultured in the presence of dextran sulfate," Biochem. J., 267, 573-577 (1990).
34. D. E. Birk, J. M. Fitch, J. B. Barbiaz, K. J. Doane, and T. F. Linsenmayer, "Collagen fibrillogenesis in vitro: Interaction of types I and V collagen regulates fibril diameter," J. Cell Biol., 95, 649-657 (1990).
35. R. G. LeBaron, A. Höök, J. D. Esko, S. Gay, and M. Höök, "Binding of heparan sulfate to type V collagen," J. Biol. Chem., 264, 7950-7956 (1989).